THE AIM ORGANIZATION ANNOUNCES LAUNCH OF GLP WEIGHT MANAGEMENT PROGRAM
| PROJECTED TO GENERATE OVER $5 MILLION PER YEAR IN POTENTIAL REVENUE |
| IMPROVE HEALTH OUTCOMES FOR MORE THAN AIM’S 23,000 PATIENT PORTFOLIO |
| The AIM Organization is pleased to announce the upcoming launch of its GLP Weight Management Program, designed to enhance the health and mobility of up to 23,000 patients across its clinical network. This initiative not only advances AIM’s mission of improving outcomes for individuals with ambulatory disabilities and osteoarthritis, but also represents a substantial growth opportunity across the organization’s multi-state footprint. Based on program modeling and expected patient participation, AIM sees potential total revenue impact exceeding $5 million per year as the company scales, with an average revenue per patient estimated at approximately $2,500/year. Closing just 5% of the 23,000 patient portfolio would result in an additional 2.8 milliion in revenue. The program complements AIM’s existing licensed pharmacy operations and regenerative medicine services, positioning the organization to capture meaningful market share in the rapidly expanding GLP-based weight-management sector—an industry estimated to surpass $100 billion globally by 2030. Effective weight management plays a critical role in reducing fall risk and improving quality of life for millions of adults living with chronic joint conditions. Studies show that more than 70% of seniors with severe osteoarthritis, AIM’s primary demographic, also struggle with obesity, and even a modest 5% reduction in body weight can significantly improve ambulatory health and independence. “We believe this program will have a profound impact not only on our patients but also on the referring physicians who trust us with their care,” said Ralph Lombardo, Chief Executive Officer of the AIM Organization. We currently have more than 23,000 patients who we have either treated or have engaged in live interaction with expressed interest in our services. Our GLP protocol brings together advanced medical oversight, structured follow-up, and measurable results to drive sustained improvement in mobility and overall health outcomes.” In addition to patient-care benefits, AIM’s GLP Weight Management Program will serve as a scalable platform that integrates metabolic and musculoskeletal health interventions under one coordinated care model. The organization anticipates a strong early-adoption curve driven by its established diabetic and osteoarthritis patient base, where more than 50% of patients currently manage diabetes and over 70% are diagnosed with obesity at intake. About AIM AIM owns and operates a network of profitable clinics, specializing in chronic pain, obesity, and comprehensive ambulatory functions. Known for its innovative approach and patient-centered care, AIM is dedicated to improving patient outcomes and enhancing the quality of life. |
| To Invest or for more information, please contact: David Fann President david.fann@theaimorganization.com 904.251.4910 www.theaimorganization.com |